Clinical trial
A Phase 2 Clinical Trial to Test the Safety and Efficacy of Etravirine in Friedreich Ataxia Patients
NCT04273165 is registered in ClinicalTrials.gov with IRCCS Eugenio Medea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Clinical Trial to Test the Safety and Efficacy of Etravirine in Friedreich Ataxia Patients
- Lead sponsor
- IRCCS Eugenio Medea
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 17, 2020
- Completion date
- January 17, 2023
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.